Jane Castelli‐Haley

1.8k total citations
45 papers, 1.4k citations indexed

About

Jane Castelli‐Haley is a scholar working on Pathology and Forensic Medicine, Reproductive Medicine and Neurology. According to data from OpenAlex, Jane Castelli‐Haley has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 15 papers in Reproductive Medicine and 14 papers in Neurology. Recurrent topics in Jane Castelli‐Haley's work include Multiple Sclerosis Research Studies (15 papers), Endometriosis Research and Treatment (15 papers) and Uterine Myomas and Treatments (10 papers). Jane Castelli‐Haley is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Endometriosis Research and Treatment (15 papers) and Uterine Myomas and Treatments (10 papers). Jane Castelli‐Haley collaborates with scholars based in United States, Canada and United Kingdom. Jane Castelli‐Haley's co-authors include Ahmed M. Soliman, MerriKay Oleen-Burkey, Maureen J. Lage, Eric S. Surrey, Karin S. Coyne, Lucinda Orsini, Gregory Lenhart, Daniel M. Huse, Sean K. Kennedy and Michael C. Snabes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Fertility and Sterility.

In The Last Decade

Jane Castelli‐Haley

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Castelli‐Haley United States 19 561 439 394 343 288 45 1.4k
Judith S. Brand Sweden 21 136 0.2× 89 0.2× 36 0.1× 121 0.4× 148 0.5× 43 1.3k
Amanda Vincent Australia 24 505 0.9× 127 0.3× 32 0.1× 154 0.4× 461 1.6× 86 1.6k
Shinji Satoh Japan 14 310 0.6× 360 0.8× 21 0.1× 52 0.2× 177 0.6× 44 1.1k
Ekta Kapoor United States 16 100 0.2× 57 0.1× 31 0.1× 143 0.4× 174 0.6× 41 1.1k
Shari Clifton United States 15 619 1.1× 95 0.2× 18 0.0× 20 0.1× 418 1.5× 54 1.2k
Börge Schmidt Germany 15 24 0.0× 115 0.3× 176 0.4× 56 0.2× 128 0.4× 110 792
Dagmar l’Allemand Switzerland 27 128 0.2× 30 0.1× 50 0.1× 105 0.3× 412 1.4× 80 2.2k
Cheng‐Che Shen Taiwan 19 168 0.3× 16 0.0× 165 0.4× 131 0.4× 153 0.5× 41 1.1k
Lindsay Fraser United Kingdom 18 221 0.4× 47 0.1× 8 0.0× 162 0.5× 183 0.6× 40 1.3k
Beda Hartmann Austria 21 204 0.4× 317 0.7× 8 0.0× 45 0.1× 245 0.9× 64 1.2k

Countries citing papers authored by Jane Castelli‐Haley

Since Specialization
Citations

This map shows the geographic impact of Jane Castelli‐Haley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Castelli‐Haley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Castelli‐Haley more than expected).

Fields of papers citing papers by Jane Castelli‐Haley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Castelli‐Haley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Castelli‐Haley. The network helps show where Jane Castelli‐Haley may publish in the future.

Co-authorship network of co-authors of Jane Castelli‐Haley

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Castelli‐Haley. A scholar is included among the top collaborators of Jane Castelli‐Haley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Castelli‐Haley. Jane Castelli‐Haley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Matthew, Ahmed M. Soliman, Jane Castelli‐Haley, Michael C. Snabes, & Eric S. Surrey. (2018). Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids. Journal of Women s Health. 27(10). 1204–1214. 42 indexed citations
2.
3.
Soliman, Ahmed M., et al.. (2018). Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States. Advances in Therapy. 35(3). 408–423. 113 indexed citations
4.
Soliman, Ahmed M., et al.. (2017). Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States. Fertility and Sterility. 107(5). 1181–1190.e2. 36 indexed citations
5.
Soliman, Ahmed M., et al.. (2017). Examining the Relationship Between Symptomatic Burden and Self-reported Productivity Losses Among Patients With Uterine Fibroids in the United States. Journal of Occupational and Environmental Medicine. 59(10). 974–981. 14 indexed citations
6.
Castelli‐Haley, Jane, et al.. (2016). Health-Related Productivity Losses Due to Endometriosis in the United States: Evidence from a Cross-Sectional Survey. Value in Health. 19(3). A177–A177. 1 indexed citations
7.
Soliman, Ahmed M., Machaon Bonafede, Amanda M. Farr, Jane Castelli‐Haley, & Craig A. Winkel. (2016). Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy. Journal of Managed Care & Specialty Pharmacy. 22(5). 573–587. 4 indexed citations
8.
Johnson, Scott J., Anna Kaltenboeck, Howard G. Birnbaum, et al.. (2013). Costs of Parkinson’s Disease in a Privately Insured Population. PharmacoEconomics. 31(9). 799–806. 24 indexed citations
9.
Oleen-Burkey, MerriKay, Jane Castelli‐Haley, Maureen J. Lage, & Kenneth P. Johnson. (2012). Burden of a Multiple Sclerosis Relapse. Patient. 5(1). 57–69. 70 indexed citations
10.
Rendas‐Baum, Regina, Philip O. Buck, Michelle K. White, & Jane Castelli‐Haley. (2011). Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in parkinson's disease. Health and Quality of Life Outcomes. 9(1). 69–69. 2 indexed citations
11.
Oleen-Burkey, MerriKay, Avi Dor, Jane Castelli‐Haley, & Maureen J. Lage. (2011). The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate. Journal of Medical Economics. 14(6). 739–747. 36 indexed citations
12.
Castelli‐Haley, Jane, et al.. (2010). Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence. ˜The œAmerican journal of geriatric pharmacotherapy. 8(4). 374–383. 51 indexed citations
13.
Castelli‐Haley, Jane, MerriKay Oleen-Burkey, Maureen J. Lage, & Kenneth P. Johnson. (2010). Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts. Journal of Medical Economics. 13(3). 464–471. 14 indexed citations
14.
Dor, Avi, et al.. (2010). cost sharing, benefit design, and adherence: The case of multiple sclerosis. PubMed. 22. 175–193. 33 indexed citations
15.
Earnshaw, Stephanie, James E. Graham, MerriKay Oleen-Burkey, Jane Castelli‐Haley, & K. B. Johnson. (2009). Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis. Applied Health Economics and Health Policy. 7(2). 91–108. 33 indexed citations
16.
Castelli‐Haley, Jane, MerriKay Oleen-Burkey, Maureen J. Lage, & Kenneth P. Johnson. (2009). Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis. Advances in Therapy. 26(5). 552–562. 18 indexed citations
17.
Ollendorf, Daniel A., Jane Castelli‐Haley, & MerriKay Oleen-Burkey. (2008). Impact of Co-Prescribed Glatiramer Acetate and Antihistamine Therapy on the Likelihood of Relapse Among Patients with Multiple Sclerosis. Journal of Neuroscience Nursing. 40(5). 281–290. 12 indexed citations
18.
Castelli‐Haley, Jane, et al.. (2008). Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients. Advances in Therapy. 25(7). 658–673. 12 indexed citations
19.
Bell, Christopher F., James E. Graham, Stephanie Earnshaw, et al.. (2007). Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data. Journal of Managed Care Pharmacy. 13(3). 245–261. 90 indexed citations
20.
Lage, Maureen J., et al.. (2006). Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosis. Work. 27(2). 143–151. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith S. Brand Breakdown of academic impact, for papers by Amanda Vincent Breakdown of academic impact, for papers by Shinji Satoh Breakdown of academic impact, for papers by Ekta Kapoor Breakdown of academic impact, for papers by Shari Clifton Breakdown of academic impact, for papers by Börge Schmidt Breakdown of academic impact, for papers by Dagmar l’Allemand Breakdown of academic impact, for papers by Cheng‐Che Shen Breakdown of academic impact, for papers by Lindsay Fraser Breakdown of academic impact, for papers by Beda Hartmann
Rankless by CCL
2026